These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 2892445)

  • 1. The comparative pharmacokinetics of H1-receptor antagonists.
    Simons FE; Simons KJ; Chung M; Yeh J
    Ann Allergy; 1987 Dec; 59(6 Pt 2):20-4. PubMed ID: 2892445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical pharmacokinetics of H1-receptor antagonists (the antihistamines).
    Paton DM; Webster DR
    Clin Pharmacokinet; 1985; 10(6):477-97. PubMed ID: 2866055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Non-sedative antihistaminics and binding to central and peripheral H1 histamine receptors].
    Leysen JE; Gommeren W; Janssen PF; Sanz G; Gillardin JM; Schotte A; Janssen PA
    Allerg Immunol (Paris); 1991 Feb; 23(2):51-7. PubMed ID: 1677249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in H1-receptor antagonist treatment.
    Simons FE
    J Allergy Clin Immunol; 1990 Dec; 86(6 Pt 2):995-9. PubMed ID: 1979802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. H1-receptor antagonist treatment of seasonal allergic rhinitis.
    Kaiser HB
    J Allergy Clin Immunol; 1990 Dec; 86(6 Pt 2):1000-3. PubMed ID: 1979793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacology of antihistamines.
    Woodward JK
    J Allergy Clin Immunol; 1990 Oct; 86(4 Pt 2):606-12. PubMed ID: 1977782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonsedating histamine H1-receptor antagonists.
    Mann KV; Crowe JP; Tietze KJ
    Clin Pharm; 1989 May; 8(5):331-44. PubMed ID: 2568212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic optimisation of histamine H1-receptor antagonist therapy.
    Simons FE; Simons KJ
    Clin Pharmacokinet; 1991 Nov; 21(5):372-93. PubMed ID: 1685361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroxyzine and cetirizine pharmacokinetics and pharmacodynamics after oral and intravenous administration of hydroxyzine to healthy dogs.
    Bizikova P; Papich MG; Olivry T
    Vet Dermatol; 2008 Dec; 19(6):348-57. PubMed ID: 18980631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind, single-dose, crossover comparison of cetirizine, terfenadine, loratadine, astemizole, and chlorpheniramine versus placebo: suppressive effects on histamine-induced wheals and flares during 24 hours in normal subjects.
    Simons FE; McMillan JL; Simons KJ
    J Allergy Clin Immunol; 1990 Oct; 86(4 Pt 1):540-7. PubMed ID: 1977781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single dose pharmacokinetics of cetirizine in young and elderly volunteers.
    Lefebvre RA; Rosseel MT; Bernheim J
    Int J Clin Pharmacol Res; 1988; 8(6):463-70. PubMed ID: 2908109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the potential cardiotoxicity of the antihistamines terfenadine, astemizole, loratadine, and cetirizine in atopic children.
    Delgado LF; Pferferman A; Solé D; Naspitz CK
    Ann Allergy Asthma Immunol; 1998 Apr; 80(4):333-7. PubMed ID: 9564984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological modulation of cutaneous reactivity to histamine: a double-blind acute comparative study between cetirizine, terfenadine and astemizole.
    Ghys L; Rihoux JP
    J Int Med Res; 1989; 17(1):24-7. PubMed ID: 2565265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative analysis of the cardiotoxicity proclivities of second generation antihistamines in an experimental model predictive of adverse clinical ECG effects.
    Hey JA; del Prado M; Sherwood J; Kreutner W; Egan RW
    Arzneimittelforschung; 1996 Feb; 46(2):153-8. PubMed ID: 8720304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of the cutaneous response to histamine by H1-blocking agents. Quantitative evaluation of microvascular changes in the skin after histamine challenge and a comparison of the effects of a single intake of cetirizine and terfenadine.
    Van Neste D; Rihoux JP
    Skin Pharmacol; 1988; 1(3):192-9. PubMed ID: 2908486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of urticaria and angioedema: low-sedating H1-type antihistamines.
    Soter NA
    J Am Acad Dermatol; 1991 Jun; 24(6 Pt 2):1084-7. PubMed ID: 1677011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic overview of oral second-generation H1 antihistamines.
    González MA; Estes KS
    Int J Clin Pharmacol Ther; 1998 May; 36(5):292-300. PubMed ID: 9629995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of cetirizine in 2- to 6-year-old children.
    Pariente-Khayat A; Rey E; Dubois MC; Vauzelle-Kervroedan F; Pons G; D'athis P; Murat II; Pinelli ME; Saint-Maurice C; Olive G
    Int J Clin Pharmacol Ther; 1995 Jun; 33(6):340-4. PubMed ID: 7582385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The second-generation antihistamines. What makes them different?
    Ryhal BT; Fletcher MP
    Postgrad Med; 1991 May; 89(6):87-8, 91-4, 99. PubMed ID: 1673571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and pharmacodynamics of cetirizine in infants and toddlers.
    Spicák V; Dab I; Hulhoven R; Desager JP; Klánová M; de Longueville M; Harvengt C
    Clin Pharmacol Ther; 1997 Mar; 61(3):325-30. PubMed ID: 9084458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.